You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chimeric Antigen Receptor T cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

Not yet recruiting
  • Kidney Transplant
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Study of Participants Who ReceivedAllogeneic CAR T-Cell Product

Recruiting
  • Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
    • Culver City, California
      Science 37, Inc.
    Apr 10, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Denver, Colorado
    • +1 more
    Jul 7, 2023

    Solid Tumor Trial (HER2-E-CART cells)

    Not yet recruiting
    • Solid Tumor
    • HER2-E-CART cells
    • (no location specified)
    Feb 16, 2023

    Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

    Not yet recruiting
    • Lymphomas
    • B-cell Lymphomas
    • Houston, Texas
      The University of Texas M D Anderson Cancer Center
    Mar 6, 2023

    Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

    Not yet recruiting
    • Lymphoma
    • +2 more
    • Web Application
    • San Francisco, California
      University of California, San Francisco
    Oct 4, 2022

    Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

    Not yet recruiting
    • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Nov 28, 2022

    Non Hodgkin Lymphoma Trial in San Francisco (Neuropsychological testing)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • Neuropsychological testing
    • San Francisco, California
      Stanford Cancer Center
    Nov 9, 2022

    Non-hodgkin Lymphoma, Acute Lymphocytic Leukemia Trial in Saint Louis (Duvelisib)

    Recruiting
    • Non-hodgkin Lymphoma
    • Acute Lymphocytic Leukemia
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 30, 2022

    Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • CD19-targeted chimeric antigen receptor T-cell
    • Kaohsiung, Taiwan
    • +2 more
    Oct 25, 2022

    Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia Trial in Beijing

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • chimeric antigen receptor T cell
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Aug 12, 2022

    Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in Milwaukee (Belantamab mafodotin)

    Recruiting
    • Refractory Multiple Myeloma
    • Relapse Multiple Myeloma
    • Belantamab mafodotin
    • Milwaukee, Wisconsin
      Froedtert & the Medical College of Wisconsin
    Aug 3, 2022

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)

    Not yet recruiting
    • B-All
    • Acute Lymphoblastic Leukemia
    • NGS testing
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    Advanced Hepatocellular Carcinoma Trial (EU307 CAR-T Cell)

    Not yet recruiting
    • Advanced Hepatocellular Carcinoma
    • EU307 CAR-T Cell
    • (no location specified)
    Mar 13, 2023

    Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

    Recruiting
    • Malignant Neoplasm
    • +4 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Cardiovascular Events Among Adults Relapsed or Refractory

    Recruiting
    • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
    • +9 more
    • Electronic Health Record Review
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    CAR-T Treatment for Hematological Malignancies

    Recruiting
    • Hematological Malignancies
    • Chimeric Antigen Receptor T-cell Therapy
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Sep 11, 2023

      Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

      Not yet recruiting
      • Relapsed/ Refractory Multiple Myeloma
      • GC012F
      • (no location specified)
      Apr 28, 2023

      T Cell Lymphoblastic Lymphoma Trial in Beijing (BT-007 CD7 CAR-T cells)

      Recruiting
      • T Cell Lymphoblastic Lymphoma
      • BT-007 CD7 CAR-T cells
      • Beijing, China
        Beijing Cancer Hospital
      Sep 22, 2022

      Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

      Recruiting
      • Liver Carcinoma
      • Hepatic Cell Carcinoma
      • CAR-GPC3 T cells
      • Wuhan, Hubei, China
        Tao Zhang
      Nov 20, 2023

      Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

      Not yet recruiting
      • Recurrent Diffuse Large B-Cell Lymphoma
      • Refractory Diffuse Large B-Cell Lymphoma
      • Biospecimen Collection
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Mar 24, 2023